Pfizer Targets Growth Recovery by 2029 Amid Portfolio Shifts
Pfizer is executing a multi-year plan aimed at restoring revenue growth by 2029 after recent product transitions.
Topic cluster
1 source grouped by AFBytes in Economy
AFBytes briefing
Pfizer performance influences holdings in many retirement and index funds held by American investors.
What to watch next
Pfizer is executing a multi-year plan aimed at restoring revenue growth by 2029 after recent product transitions.